SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 485 filers reported holding SEAGEN INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,489,717 | +7.5% | 7,022 | -2.5% | 0.04% | +7.1% |
| Q2 2023 | $1,385,520 | +0.8% | 7,199 | +6.0% | 0.04% | -12.5% |
| Q1 2023 | $1,374,771 | +125.7% | 6,790 | +43.2% | 0.05% | +92.0% |
| Q4 2022 | $609,137 | -28.2% | 4,740 | -23.5% | 0.02% | -34.2% |
| Q3 2022 | $848,000 | -12.5% | 6,194 | +13.1% | 0.04% | -15.6% |
| Q2 2022 | $969,000 | +53.8% | 5,478 | +25.3% | 0.04% | +50.0% |
| Q1 2022 | $630,000 | +11.5% | 4,373 | +19.6% | 0.03% | -9.1% |
| Q4 2021 | $565,000 | -2.4% | 3,655 | +7.2% | 0.03% | -36.5% |
| Q3 2021 | $579,000 | +24.0% | 3,408 | +15.1% | 0.05% | +6.1% |
| Q2 2021 | $467,000 | +57.8% | 2,960 | +38.9% | 0.05% | +8.9% |
| Q1 2021 | $296,000 | +46.5% | 2,131 | +84.3% | 0.04% | +2.3% |
| Q4 2020 | $202,000 | – | 1,156 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |